Skip to content
Screener

Shares (Diluted) at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
105.4M-1.1%
Biogen logo
BiogenBIIB
148.7M+1.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
103.4M+0.9%
Insmed logo
InsmedINSM
217.4M+14.8%
Regenxbio logo
RegenxbioRGNX
53M+3.0%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
107.1M+12.6%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.4M-37.6%
Net income-$54.8M-38.8%
EPS (diluted)-$0.38+9.5%

Balance sheet

See full
Cash & equivalents$159.4M+14.7%
Total debt$20.2M-12.6%
Total equity$374.1M+44.8%
Total assets$420.6M+36.4%

Cash flow

See full
Operating cash flow-$52.6M-40.6%
CapEx$150.0K-60.2%
Free cash flow-$52.7M-39.6%

Valuation

See full
Market cap$899.62M+90.9%
Enterprise value$760.38M+114%

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-65.5%-2.5pp
Debt / equity0.1×0.0×
Current ratio13.8×+4.5×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-337935

FAQ

What is Solid Biosciences Inc.'s shares (diluted)?
Solid Biosciences Inc. (SLDB) reported shares (diluted) of 143.7M in Q2 2026.
How has Solid Biosciences Inc.'s shares (diluted) changed year-over-year?
Solid Biosciences Inc.'s shares (diluted) increased by 52.6% year-over-year, from 94.1M to 143.7M.
What is the long-term trend for Solid Biosciences Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Solid Biosciences Inc.'s shares (diluted) has grown at a 12.2% compound annual growth rate (CAGR), from 216.2M to 342.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Solid Biosciences Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude